Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 4
1992 1
1993 1
1994 1
1995 1
1997 1
1998 2
1999 1
2000 1
2001 1
2002 1
2003 1
2005 2
2008 3
2009 2
2010 2
2011 3
2012 3
2013 10
2014 7
2015 6
2016 5
2017 3
2018 6
2019 3
2020 11
2021 13
2022 9
2023 8
2024 5
2025 11
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. ADVANCE Collaborative Group, et al. N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539916 Free article. Clinical Trial.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Editorial: Model organisms in respiratory pharmacology 2023.
McCarron A, Surolia R, Ruffini L. McCarron A, et al. Among authors: ruffini l. Front Pharmacol. 2025 Jan 13;15:1540222. doi: 10.3389/fphar.2024.1540222. eCollection 2024. Front Pharmacol. 2025. PMID: 39872054 Free PMC article. No abstract available.
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Leonetti A, Cervati V, Minari R, Scarlattei M, Verzè M, Peroni M, Pluchino M, Bonatti F, Perrone F, Mazzaschi G, Cosenza A, Gnetti L, Bordi P, Ruffini L, Tiseo M. Leonetti A, et al. Among authors: ruffini l. Clin Lung Cancer. 2024 Dec;25(8):e436-e445.e9. doi: 10.1016/j.cllc.2024.07.016. Epub 2024 Aug 6. Clin Lung Cancer. 2024. PMID: 39198088
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914).
Francolini G, Garlatti P, Di Cataldo V, Caini S, Loi M, Simontacchi G, Desideri I, Greto D, Burchini L, Bonaparte I, Frosini G, Serni S, Campi R, Vaggelli L, Bertini N, Aquilano M, Simoni N, Colombo F, Franzese C, Scorsetti M, Chiti A, Ruffini L, Raspollini MR, Roach M, Valicenti RK, Livi L. Francolini G, et al. Among authors: ruffini l. Radiol Med. 2025 Oct 13. doi: 10.1007/s11547-025-02107-7. Online ahead of print. Radiol Med. 2025. PMID: 41081978
Emerging Radioligands as Tools to Track Multi-Organ Senescence.
Gagliardi A, Migliari S, Guercio A, Baldari G, Graziani T, Cervati V, Ruffini L, Scarlattei M. Gagliardi A, et al. Among authors: ruffini l. Diagnostics (Basel). 2025 Oct 4;15(19):2518. doi: 10.3390/diagnostics15192518. Diagnostics (Basel). 2025. PMID: 41095737 Free PMC article. Review.
Transarterial embolization for infants under 3 months of age with refractory seizures due to hemimegalencephaly: complication analysis and evolution of treatment strategy.
Pearl MS, Anwar T, Israel S, Ruffini L, Kratimenos P, Spagnolo K, Chen WL, Berl M, Gaillard WD, Tsuchida TN, Oluigbo C. Pearl MS, et al. Among authors: ruffini l. J Neurointerv Surg. 2025 May 27:jnis-2025-023551. doi: 10.1136/jnis-2025-023551. Online ahead of print. J Neurointerv Surg. 2025. PMID: 40425282
121 results